BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Endocrine gland cancer AND PCM1, Q15154, PTC4, ENSG00000078674, 5108
10 results:

  • 1. Loss of ATG4B and ATG4A results in two-stage cell cycle defects in pancreatic ductal adenocarcinoma cells.
    Sathiyaseelan P; Chittaranjan S; Kalloger SE; Chan J; Go NE; Jardon MA; Ho CJ; Hui T; Xu J; Chow C; Gao D; Johnson FD; Lockwood WW; Morin GB; Renouf DJ; Schaeffer DF; Gorski SM
    J Cell Sci; 2023 Oct; 136(19):. PubMed ID: 37701987
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. TERT Gene Fusions Characterize a Subset of Metastatic Leydig Cell Tumors.
    Kruslin B; Gatalica Z; Hes O; Skenderi F; Miettinen M; Contreras E; Xiu J; Ellis M; Florento E; Vranic S; Swensen J
    Clin Genitourin Cancer; 2021 Aug; 19(4):333-338. PubMed ID: 33741265
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. [Surgery for gastrinoma: Short and long-term results].
    Fernández-Cruz L; Pelegrina A
    Cir Esp; 2015; 93(6):390-5. PubMed ID: 25748044
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Targeted resequencing of the microRNAome and 3'UTRome reveals functional germline DNA variants with altered prevalence in epithelial ovarian cancer.
    Chen X; Paranjape T; Stahlhut C; McVeigh T; Keane F; Nallur S; Miller N; Kerin M; Deng Y; Yao X; Zhao H; Weidhaas JB; Slack FJ
    Oncogene; 2015 Apr; 34(16):2125-37. PubMed ID: 24909162
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Inhibition of Aurora-A kinase induces cell cycle arrest in epithelial ovarian cancer stem cells by affecting NFĸB pathway.
    Chefetz I; Holmberg JC; Alvero AB; Visintin I; Mor G
    Cell Cycle; 2011 Jul; 10(13):2206-14. PubMed ID: 21623171
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Five genes from chromosomal band 8p22 are significantly down-regulated in ovarian carcinoma: N33 and EFA6R have a potential impact on overall survival.
    Pils D; Horak P; Gleiss A; Sax C; Fabjani G; Moebus VJ; Zielinski C; Reinthaller A; Zeillinger R; Krainer M
    Cancer; 2005 Dec; 104(11):2417-29. PubMed ID: 16270321
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Differential pattern of integrin receptor expression in differentiated and anaplastic thyroid cancer cell lines.
    Hoffmann S; Maschuw K; Hassan I; Reckzeh B; Wunderlich A; Lingelbach S; Zielke A
    Thyroid; 2005 Sep; 15(9):1011-20. PubMed ID: 16187909
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. RET/PCM-1: a novel fusion gene in papillary thyroid carcinoma.
    Corvi R; Berger N; Balczon R; Romeo G
    Oncogene; 2000 Aug; 19(37):4236-42. PubMed ID: 10980597
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Molecular and biochemical analysis of RET/ptc4, a novel oncogenic rearrangement between RET and ELE1 genes, in a post-Chernobyl papillary thyroid cancer.
    Fugazzola L; Pierotti MA; Vigano E; Pacini F; Vorontsova TV; Bongarzone I
    Oncogene; 1996 Sep; 13(5):1093-7. PubMed ID: 8806699
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Sequential granulocyte colony-stimulating factor increases cisplatin cytotoxicity in human epithelial ovarian cancer cell lines.
    Fanning J; Hilgers RD; Kane C; Medrano C
    Gynecol Oncol; 1996 Mar; 60(3):450-3. PubMed ID: 8774656
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.